PIPELINE
SoVarGen will continue to expand competitive pipelines through our
proprietary science and technology.
- SoVarGen R&D Pipeline
- Neurodevelopmental disorders Brain Tumor Neurodegenerative diseases
Pipeline / Indication | Discovery | Pre-clinical | Clinical | |||
---|---|---|---|---|---|---|
Target identification |
Lead optimization |
Proof of concept |
IND-enabling studies |
Phase 1 | Phase 2 | |
SVG101 Intractable focal epilepsy |
|
|||||
SVG102 Intractable focal epilepsy |
|
|||||
SVG103 Non-disclosure |
|
|||||
SVG104 Non-disclosure |
|
|||||
SVG301 Non-disclosure |
|
|||||
SVG302 Glioblastoma multiforme |
|
|||||
SVG501 Alzheimer’s disease |
|
SVG101 FCD 2
SVG102 FCD 2
SVG103 Non-disclosure
SVG104 Non-disclosure
SVG301 Non-disclosure
SVG302 Glioblastoma multiforme
SVG501 Alzheimer’s disease
Partnership
SoVarGen will expedite and strengthen drug development with our unique
science and technology and also through open collaboration with global partners.
-
Bioinformatics & Artificial Intelligence
SoVarGen is awaiting its partners to collaborate on articulating root causes and mechanisms of CNS diseases and create a transformational long-term platform.- Programs for Cooperation
-
- Genomic data base target discovery
- In vitro and in vivo Target validation
- RNA drugs candidate screening & optimization
-
RNA
SoVarGen is awaiting its partners to design and materialize a new gene treatment technology
Therapeutics- Programs for Cooperation
-
- ASO, siRNA therapy
- mRNA therapy
- chemical modification of ASO, siRNA, mRNA
- Gene editing
-
Delivery System Development
SoVarGen is awaiting its partners to develop new drug delivery systems by which the in vivo stability and the permeability of the blood-brain barrier or BBB, will be further enhanced.- Programs for Cooperation
-
- Liposome
- Exosome
- Viral Vector
-
New Disease Models
SoVarGen is awaiting its partners to build disease-specific animal models with the new gene -editing technology to validate the stability and effectiveness of candidate substances.- Programs for Cooperation
-
- Human brain organoid, iPSC
- Genetic engineered animal model